1Zhu Junren, Han Qingqin. Zhongshan Hospital, Shanghai Medical University, Shanghai 100032 Shanghai multicenter clinical study group ).微粒化非诺贝特治疗高脂血症疗效和耐受性[J].中华心血管病杂志,1997,25(3):180-183. 被引量：16
3Riegger G, Abletshauser C, Ludwig M, et al. The effect of flux' astatin on cardiac events in patients with symptomatic coronary artery disease during one year treatment[J] . Atherosclerosis,1999,144 ( 1 ) :263 - 270.
4Downs JR,Clearfield M. Wels S. et al. Primary prevention of acute corenary events with lovastatin in men and women with average choles-terol levels, Results of AFCAPS/TexCAPS [ J ].JAMA, 1998,279(20) : 1615 - 1622.
5王家良.循证医学（第1版）[M].北京:人民卫生出版社,2001.5-50.
6David Moher, Kenneth F Schulz, Douglas G Altman, for the CONSORT Group. The CONSORT statement: revised recommendations for improving the quality of reports of paralleo-group randomized trials [J]. TheLancet, 2001; 357(4): 1 191-1 194
7Stalenhoef AF, Lansberg PJ, Kroon AA, Kortmann B, De Haan AF,Stuyt PM, Kastelein JJ. Treatment of primary hypercholesterolaemia.Short-term efficacy and safety of increasing doses of simvastatin and pravastatin: a double-blind comparative study [ J ]. J Intem Med,1993; 234(1): 77-82
8The European Study Group. Efficacy and tolerability of simvastatin and pravastatin in patients with primary hypercholesterolemia ( multicountry comparative study) [J ]. Am J Cardiol, 1992; 70 ( 15 ): 1281 - 1 286
9Lambrecht LJ, Malini PL. Efficacy and tolerability of simvastatin 20mg vs pravastatin 20 mg in patients with primary hypercholesterolemia.European Study Group[J]. Acta Cardiol, 1993; 48(6): 541 -554
10Steinhagen-Thiessen E. Comparative efficacy and tolerability of 5 and 10 mg simvastatin and 10 mg pravastatin in moderate primary hypercholesterolemia. Simvastatin Pravastatin European Study Group [J ].Cardiology, 1994; 85(3-4): 244-254
